1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,859 | 1,963 | 20:55 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.05. | Pre-market Movers: Nutanix, WalkMe, Snowflake, iSpecimen, NanoViricides | 1.009 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).In the GreenNanoViricides, Inc. (NNVC) is up over 11% at $2.22
iQIYI... ► Artikel lesen | |
| 20.05. | NNVC, BEST and PYR among mid-day movers | 5 | Seeking Alpha | ||
| 17.05. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application | 629 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| 16.05. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | - | SEC Filings | ||
| 16.05. | NanoViricides Starts Drug Development Program For Recent Cases Of Unexplained Pediatric Hepatitis | - | Benzinga.com | ||
| 16.05. | NanoViricides stock rises on starting drug screening program to fight severe hepatitis in kids | 1 | Seeking Alpha | ||
| 16.05. | NanoViricides, Inc.: NanoViricides Reports that It Has Begun Drug Development to Combat Recent Cases of Severe Pediatric Hepatitis | 599 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 16, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 25.04. | NanoViricides provides update on potential COVID drug NV-CoV-2 | - | Seeking Alpha | ||
| 25.04. | NanoViricides, Inc.: NanoViricides Provides Update On NV-CoV-2 Coronavirus Drug Candidate Program | 929 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / April 25, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 15.02. | NanoViricides GAAP EPS of -$0.17 | 4 | Seeking Alpha | ||
| 15.02. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Clinical Trials Application Ready | 710 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 15, 2022 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 14.02. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 2 | SEC Filings | ||
| 16.11.21 | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials | 969 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / November 16, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 15.11.21 | NanoViricides, Inc.: NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2 | 719 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / November 15, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 13.10.21 | NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage | 865 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021... ► Artikel lesen | |
| 11.10.21 | NanoViricides, Inc.: NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity | 407 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 05.10.21 | NanoViricides, Inc.: NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference | 670 | PR Newswire | SHELTON, Conn., Oct. 5, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel... ► Artikel lesen | |
| 27.09.21 | NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Cap Conference for Update on Pan-Coronavirus COVID-19 Drug Development Program | 788 | Newsfile | Shelton, Connecticut--(Newsfile Corp. - September 27, 2021) - NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on... ► Artikel lesen | |
| 22.09.21 | NanoViricides, Inc.: Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug | 616 | PR Newswire | SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel... ► Artikel lesen | |
| 22.09.21 | XFRA NV3P: WIEDERAUFNAHME/RESUMPTION | 457 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 79,50 | +3,25 % | Formycon: Quartalsverlust mehr als verdoppelt | Formycon hat im ersten Quartal 2022 einen Umsatzrückgang von 9,4 Millionen Euro auf 8,2 Millionen Euro verbucht. Der operative Verlust auf EBITDA-Basis hat sich von 1,7 Millionen Euro auf 4 Millionen... ► Artikel lesen | |
| MAGFORCE | 1,900 | +0,26 % | MagForce begibt an Lansdowne Investment Company Cyprus Inhaberschuldverschreibungen mit Volumen von bis zu EUR 3,5 Mio. | Bad Marienberg (www.anleihencheck.de) - Aktuelle Pressemitteilung der MagForce AG (ISIN DE000A0HGQF5/ WKN A0HGQF):Die MagForce AG (Frankfurt, Scale, Xetra: MF6,), ein führendes Medizintechnikunternehmen... ► Artikel lesen | |
| NANOGATE | 0,020 | -69,28 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 04.02.2022 | The following instruments on XETRA do have their last trading day on 04.02.2022Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 03.02.2022ISIN NameDE000A0JKHC9 NANOGATE SE I.A.INH.... ► Artikel lesen | |
| VEECO INSTRUMENTS | 18,625 | -1,95 % | 16.010 DAX etwas fester | HELLOFRESH | DELIVERY HERO | ZALANDO | ADIDAS | HENKEL | RWE | VEECO | Was passiert heute früh an den Märkten? Welche Nachrichten bewegen die Kurse? Wer steht im Rampenlicht? Unser Börsen-Frühstück für Sie: Wir werfen heute früh einen Blick auf die Erholung der zuletzt... ► Artikel lesen | |
| ZENTEK | 1,700 | -1,73 % | Zentek Ltd.: Zentek Provides Update on ZenGUARD Patent Status | GUELPH, ON /ACCESSWIRE / June 6, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that... ► Artikel lesen | |
| KOPIN | 1,170 | +2,72 % | Kopin Corporation: Kopin Subsidiary Secures $1 Million Order from Nexstar Technology (South Korea) | Forth Dimension Displays expands its Korean customer base for 3D inspection
Kopin Corporation (NASDAQ: KOPN), a leading developer of innovative wearable computing technologies and solutions, announced... ► Artikel lesen | |
| ONTO INNOVATION | 69,50 | +0,72 % | Here's Why Onto Innovation (ONTO) is an Attractive Bet Now | ||
| OBDUCAT | 0,070 | 0,00 % | Obducat receives order for production service to a value of approximately SEK 1.2 million | ||
| ACACIA RESEARCH | 4,760 | +2,15 % | Starboard-Backed Acacia Research Reportedly Offers To Buy Kohl's For About $9 Bln | WASHINGTON (dpa-AFX) - A group led by Acacia Research Corp., which activist hedge fund Starboard Value LP controls, offered to buy Kohl's Corp. (KSS) ?for $64 per share or about $9 billion in... ► Artikel lesen | |
| NVE | 46,800 | +0,86 % | Dividendenbekanntmachungen (13.05.2022) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,05 USD 0,0481 EUR ADIDAS AG DE000A1EWWW0 - 3,3 EUR AGCO CORPORATION US0010841023 0,24 USD 0,2311... ► Artikel lesen | |
| ADVANCE ZINCTEK | 1,370 | -0,72 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| NANOFOCUS | 0,300 | 0,00 % | Nanofocus: Gewinnwarnung und ein Angriff | Am 27. Dezember hat es bei Nanofocus eine Cyber-Attacke gegeben. Daher hat das Unternehmen alle IT-Systeme kontrolliert heruntergefahren. Auch wurde Strafanzeige gestellt. Derzeit wird ermittelt, wie... ► Artikel lesen | |
| RIBER | 1,662 | +1,47 % | Riber receives order for multi-4" GSMBE 49 production system | ||
| DOTZ NANO | 0,176 | 0,00 % | DOTZ NANO LIMITED: Cleansing Statement | ||
| GOMSPACE | 0,835 | +4,38 % | GomSpace A/S: GomSpace welcomes new Chief Commercial Officer to executive management team | STOCKHOLM, Feb. 24, 2022 /PRNewswire/ -- GomSpace, a globally leading manufacturer and supplier of cubesat & small satellite solutions, is pleased to announce the appointment of Thomas Pfister... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
